Women more prone to chronic diseases driven by immune system

Women more prone to chronic diseases driven by immune system

Most people will have heard the term ‘man flu’, which refers to men’s perceived tendency to exaggerate the severity of a cold or a similar minor ailment.

What most people may not know is that, generally speaking, women mount stronger immune responses to infections than men. Men are more susceptible to infections from, for example, HIV, hepatitis B, and Plasmodium falciparum (the parasite responsible for malaria).

They can also have more severe symptoms, with evidence showing they’re more likely to be admitted to hospital when infected with hepatitis B, tuberculosis, and Campylobacter jejuni (a bacteria that causes gastroenteritis), among others.

While this may be positive for women in some respects, it also means women are at greater risk of developing chronic diseases driven by the immune system, known as immune-mediated inflammatory diseases.

Here we will explore how biological factors influence immune differences between the sexes and how this affects women’s health. While we acknowledge that both sex and gender may affect immune responses, this article will focus on biological sex rather than gender.

Battle of the sexes

There are differences between the sexes at every stage of the immune response, from the number of immune cells, to their degree of activation (how ready they are to respond to a challenge), and beyond. However, the story is more complicated than that.

Our immune system evolves throughout our lives, learning from past experiences, but also responding to the physiological challenges of getting older. As a result, sex differences in the immune system can be seen from birth through puberty into adulthood and old age.

Why do these differences occur? The first part of answering this question involves the X chromosome. Females have two X chromosomes, while males have one X and one Y chromosome. The X chromosome contains the largest number of immune-related genes.

The X chromosome also has about 118 genes from a gene family that are able to stop the expression of other genes, or change how proteins are made, including those required for immunity. These gene-protein regulators are known as microRNA, and there are only two microRNA genes on the Y chromosome.

The X chromosome has more genes overall (about 900) than the Y chromosome (around 55), so female cells have evolved to switch off one of their X chromosomes. This is not like turning off a light switch, but more like using a dimmer.

About 15-25 per cent of genes on the silenced X chromosome are expressed at any given moment in any given cell. This means female cells can often express more immune-related genes and gene-protein regulators than males. This generally means a faster clearance of pathogens in females than males.

Second, men and women have varying levels of different sex hormones. Progesterone and testosterone are broadly considered to limit immune responses. While both hormones are produced by males and females, progesterone is found at higher concentrations in non-menopausal women than men, and testosterone is much higher in men than women.

The role of oestrogen, one of the main female sex hormones, is more complicated. Although generally oestrogen enhances immune responses, its levels vary during the menstrual cycle, are high in pregnancy and low after menopause.

Due in part to these genetic and hormonal factors, pregnancy and the years following are associated with heightened immune responses to external challenges such as infection.

This has been regarded as an evolutionary feature, protecting women and their unborn children during pregnancy and enhancing the mother’s survival throughout the child-rearing years, ultimately ensuring the survival of the population. We also see this pattern in other species including insects, lizards, birds and mammals.

What does this all mean?

With women’s heightened immune responses to infections comes an increased risk of certain diseases and prolonged immune responses after infections.

An estimated 75-80 per cent of all immune-mediated inflammatory diseases occur in females. Diseases more common in women include multiple sclerosis, rheumatoid arthritis, lupus, Sjogren’s syndrome, and thyroid disorders such as Graves disease.

In these diseases, the immune system is continuously fighting against what it sees as a foreign agent. However, often this perceived threat is not a foreign agent, but cells or tissues from the host. This leads to tissue damage, pain and immobility.

Women are also prone to chronic inflammation following infection. For example, after infections with Epstein Barr virus or Lyme disease, they may go on to develop chronic fatigue syndrome, another condition that affects more women than men.

This is one possible explanation for the heightened risk among pre-menopausal women of developing long COVID following infection with SARS-CoV-2, the virus that causes COVID.

Research has also revealed the presence of auto-antibodies (antibodies that attack the host) in patients with long COVID, suggesting it might be an autoimmune disease. As women are more susceptible to autoimmune conditions, this could potentially explain the sex bias seen.

However, the exact causes of long COVID, and the reason women may be at greater risk, are yet to be defined.

This paints a bleak picture, but it’s not all bad news. Women typically mount better vaccine responses to several common infections (for example, influenza, measles, mumps, rubella, hepatitis A and B), producing higher antibody levels than men.

One study showed that women vaccinated with half a dose of flu vaccine produced the same amount of antibodies compared to men vaccinated with a full dose.

However, these responses decline as women age, and particularly after menopause.

All of this shows it’s vital to consider sex when designing studies examining the immune system and treating patients with immune-related diseases.

This article is written by Helen McGettrick, Reader in Inflammation and Vascular Biology, University of Birmingham and Asif Iqbal, Associate Professor in Inflammation Biology, University of Birmingham.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

The Conversation

The Conversation

The Conversation Australia and New Zealand is a unique collaboration between academics and journalists that in just 10 years has become the world’s leading publisher of research-based news and analysis.

The Conversation Australia and New Zealand was founded in Melbourne in 2011. It now operates as a global network of sister sites with dedicated teams working in Indonesia, Spain, the UK, US, France, Africa, and Canada.